WGS
Price:
$85.22
Market Cap:
$2.43B
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Industry
Medical - Healthcare Information Services
IPO Date
2020-11-04
Stock Exchange
NASDAQ
Ticker
WGS
According to GeneDx Holdings Corp.’s latest financial reports and current stock price. The company's current ROE is -17.12%. This represents a change of 252.71% compared to the average of -4.85% of the last 4 quarters.
The mean historical ROE of GeneDx Holdings Corp. over the last ten years is -50.56%. The current -17.12% ROE has changed -66.13% with respect to the historical average. Over the past ten years (40 quarters), WGS's ROE was at its highest in in the December 2020 quarter at 38.08%. The ROE was at its lowest in in the December 2022 quarter at -121.70%.
Average
-50.56%
Median
-42.27%
Minimum
-216.39%
Maximum
74.67%
Discovering the peaks and valleys of GeneDx Holdings Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 74.67%
Minimum Annual Increase = -184.68%
Minimum Annual ROE = -216.39%
Year | ROE | Change |
---|---|---|
2024 | -21.32% | -72.34% |
2023 | -77.09% | -64.38% |
2022 | -216.39% | 242.23% |
2021 | -63.23% | -184.68% |
2020 | 74.67% | Infinity% |
The current ROE of GeneDx Holdings Corp. (WGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-104.93%
5-year avg
-60.67%
10-year avg
-50.56%
GeneDx Holdings Corp.’s ROE is less than NantHealth, Inc. (34.99%), greater than Talkspace, Inc. (-3.73%), greater than Minerva Surgical, Inc. (-111.32%),
Company | ROE | Market cap |
---|---|---|
34.99% | $302.18K | |
-3.73% | $456.77M | |
-111.32% | $888.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeneDx Holdings Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeneDx Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is GeneDx Holdings Corp.'s ROE?
How is the ROE calculated for GeneDx Holdings Corp. (WGS)?
What is the highest ROE for GeneDx Holdings Corp. (WGS)?
What is the 3-year average ROE for GeneDx Holdings Corp. (WGS)?
What is the 5-year average ROE for GeneDx Holdings Corp. (WGS)?
How does the current ROE for GeneDx Holdings Corp. (WGS) compare to its historical average?